| Announce Date | 11/21/2025 |
| EPS Normalized Actual | $0.96 (Miss by $-0.62) |
| EPS GAAP Actual | $0.96 (Miss by $-0.62) |
| Revenue Actual | $0.320837B |
| Revenue Surprise | Beat by $320.837M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.43944 |
| EPS GAAP Estimate | $1.43944 |
| Revenue Estimate | $0.377454267B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Feb 2028 | 4.15418 | 12.53 | 4.13548 | 4.17288 | 1 |
| Feb 2028 | 4.15418 | 12.53 | 4.13548 | 4.17288 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.97 | -0.02357 | 0.320837B | 8.48% | 16.63M |
| FQ3 2025 (Aug 2025) | 0.9 | 0.9 | 0.305737B | 100% | 305.74M |
| FQ2 2025 (May 2025) | 0.7 | 0.7 | 0.272121B | 100% | 272.12M |
| FQ1 2025 (Feb 2025) | 1.53 | 1.53 | 0.379199B | 100% | 379.2M |
| FQ4 2024 (Nov 2024) | 0.89 | 0.89 | 0.293618B | 100% | 293.62M |
| FQ3 2023 (Jul 2023) | 0.92 | 0.92 | 0.292428B | -3.27% | 292.43M |
| FQ2 2023 (Apr 2023) | 0.87 | 0.87 | 0.282834B | 100% | 282.83M |
| FQ1 2023 (Jan 2023) | 3.96 | 3.96 | 1.01285B | 100% | 1012.85M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
1.43944
Consensus Revenue Estimates
0.377454267B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Nov 2027) | 1.09038 | -- | 1.08498 | 1.09578 | 1 |
| FQ3 2027 (Aug 2027) | 0.95358 | -- | 0.94885 | 0.95831 | 1 |
| FQ2 2027 (May 2027) | 0.73816 | -- | 0.7345 | 0.74182 | 1 |
| FQ1 2027 (Feb 2027) | 1.58783 | -- | 1.58783 | 1.58783 | 1 |
| FQ4 2026 (Nov 2026) | 0.89919 | -7.87 | 0.89777 | 0.90061 | 1 |
| FQ3 2026 (Aug 2026) | 0.79828 | -12.74 | 0.79702 | 0.79954 | 1 |
| FQ2 2026 (May 2026) | 0.68359 | -2.4 | 0.68251 | 0.68467 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Nov 2027) | 0.35B | -- | 0.34B | 0.35B | 1 |
| FQ3 2027 (Aug 2027) | 0.33B | -- | 0.33B | 0.33B | 1 |
| FQ2 2027 (May 2027) | 0.29B | -- | 0.29B | 0.3B | 1 |
| FQ1 2027 (Feb 2027) | 0.41B | -- | 0.41B | 0.41B | 1 |
| FQ4 2026 (Nov 2026) | 0.31B | -3.41 | 0.31B | 0.31B | 1 |
| FQ3 2026 (Aug 2026) | 0.3B | -2.68 | 0.3B | 0.3B | 1 |
| FQ2 2026 (May 2026) | 0.27B | 0.72 | 0.27B | 0.27B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.99357 | 0.97 | -0.02357 | -2.43% |
| FQ3 2025 (Aug 2025) | 0.9 | 0.9 | 100% | |
| FQ2 2025 (May 2025) | 0.7 | 0.7 | 100% | |
| FQ1 2025 (Feb 2025) | 1.53 | 1.53 | 100% | |
| FQ4 2024 (Nov 2024) | 0.89 | 0.89 | 100% | |
| FQ3 2023 (Jul 2023) | 0.92 | 0.92 | 100% | |
| FQ2 2023 (Apr 2023) | 0.87 | 0.87 | 100% | |
| FQ1 2023 (Jan 2023) | 3.96 | 3.96 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0.3B | $0.32B | $16.63M | 5.18% |
| FQ3 2025 (Aug 2025) | $0B | $0.31B | $305.74M | 100% |
| FQ2 2025 (May 2025) | $0B | $0.27B | $272.12M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $0.38B | $379.2M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $0.29B | $293.62M | 100% |
| FQ3 2023 (Jul 2023) | $0B | $0.29B | $292.43M | 100% |
| FQ2 2023 (Apr 2023) | $0B | $0.28B | $282.83M | 100% |
| FQ1 2023 (Jan 2023) | $0B | $1.01B | $1012.85M | 100% |